Tobramycin
- Product NDC
- 0093-4085
- 11-digit product format
- 000934085
- Labeler code
- 0093
- Product ID
- 0093-4085_2aeb6242-a55e-4e45-96df-f2d26616e167
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tobramycin
- Dosage form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA091589
- Marketing category
- ANDA
- Marketing start
- 2013-11-19
- Substance
- TOBRAMYCIN
- Active strength
- 300 mg/5mL
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tobramycin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOBRAMYCIN | 300 mg/5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | VZ8RRZ51VK |
| Rxcui | 348719 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f297c7c1-845a-4369-8c02-c51b92d6ae8e | Product name | 3 | 20240725 |
| 551d952d-4ce2-24f0-9ab0-630ad9aae596 | Product name | 2 | 20231211 |
| 941f67d9-7f03-56d2-750c-36de24f654db | Product name | 3 | 20221117 |
| 9cfa145f-dbe9-bc02-83c2-692786ef6676 | Product name | 9 | 20210928 |
| 2f9713b8-5e7e-bbcc-b364-1b2c27a63796 | Product name | 4 | 20210903 |
| 32a533bc-01c7-2b9f-bbf7-ecfb0d964277 | Product name | 4 | 20210625 |
| 9f5124fb-08b0-4c3e-8e12-a1a6ff310cba | Product name | 1 | 20150309 |
| 745a62af-e1c0-4ca3-6d6e-2b6455b903be | Product name | 1 | 20140508 |
| 9ea85abb-fa68-5da6-ab60-2c7eef579000 | Product name | 1 | 20140508 |
| aa1cd319-ece7-51f7-3a9d-52a64f5f4e81 | Product name | 1 | 20140508 |
| d029211e-5e6b-725f-3696-ac6ff77da222 | Product name | 1 | 20140508 |
| ef5b7aed-2b01-3ba8-5a1c-3bc9c9f03bb1 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-4085-63 | Tobramycin | 5 mL in 1 AMPULE | SOLUTION | 5 | 11 | |
| 0093-4085-63 | Tobramycin | 56 in 1 CARTON | SOLUTION | 56 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-4085-63 | ML - Milliliter | 0093-4085 | e5ae01b3-9864-4471-8184-79489b693d3a | 1 | 2013-12-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TOBRAMYCIN | ACTIVE INGREDIENT | VZ8RRZ51VK | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 | |
| TOBRAMYCIN | ACTIVE MOIETY | VZ8RRZ51VK | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 | |
| NITROGEN | INACTIVE INGREDIENT | N762921K75 | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | TOBRAMYCIN SOLUTION [TEVA PHARMACEUTICALS USA INC] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 348719 | tobramycin 300 MG in 5 ML Inhalation Solution | PSN | c5f65e5b-c851-45da-a0e8-215d9a4e6ad3 | 11 |
| 348719 | tobramycin 60 MG/ML Inhalation Solution | SCD | c5f65e5b-c851-45da-a0e8-215d9a4e6ad3 | 11 |
| 348719 | tobramycin 300 MG per 5 ML Inhalation Solution | SY | c5f65e5b-c851-45da-a0e8-215d9a4e6ad3 | 11 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0093-4085-63 | 00093408563 | 56 AMPULE in 1 CARTON (0093-4085-63) / 5 mL in 1 AMPULE | 56 ampule | 2013-11-19 | 0000-00-00 | No | No | Current |